TNF and neoplasm: Intratumoral treatment resulted in dose-dependent increases in IL-6 and TNFα in both tumor and serum at early time points (Fig. 1d, e and Supplementary Fig. 1b, c), yet, the magnitude and duration of the response were substantially higher within tumors.